NCT06767449View on ClinicalTrials.gov

Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Advanced Gastric Cancer
Trial Locations (1)

03722

RECRUITING

Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER